Respiratory Virus

Approvals News

Xocova (Ensitrelvir): First Oral COVID-19 PEP Drug by Japan’s Shionogi
Healthcare News

Hantavirus Cruise Ship Outbreak Leaves 3 Dead, WHO Investigates Source
Blogs

Why RSV Protection for Infants in Canada Demands Awareness, Equity and Preparedness
Approvals News

Merck’s Enflonsia Gets FDA Nod for Infant RSV Protection to Rival Sanofi and AstraZeneca’s Beyfortus
Blogs

International Day of Epidemic Preparedness 2024: Amplifying Global Resilience
Biotech News

Polyrizon IPO Strengthens Momentum in Non-Invasive Drug Delivery Solutions
Life Science Podcast

Innovative Approaches to Antiviral Drug Development
Biotech News

Arexvy Shows Strong Efficacy Over Three RSV Seasons in New Phase III Data
Approvals News

Moderna’s mRESVIA Wins FDA Approval as First mRNA RSV Vaccine
Life Science Podcast

Exploring Next-Gen Antivirals ft. Sam Lee, PhD, Co-CEO & President, Cocrystal Pharma – Xtalks Life Science Podcast Ep. 161
Biotech Blogs

Leaders in Flu Defense: Insights into the 2024/25 Influenza Vaccine Strategy

NGS Strategies for Vaccine Development and Surveillance of Respiratory Viruses

May 01, 2024
Biotech Blogs

Arexvy Versus Abrysvo: How Do The RSV Vaccines Compare?

Infectious Disease Diagnostics for Influenza, RSV and SARS-CoV-2

March 05, 2024
Biotech News

Updated COVID Vaccines Targeting Omicron Subvariant Get CDC Backing
Blogs

World’s First RSV Vaccine + First Novel Treatment for ALS – Xtalks Life Science Podcast Ep. 109